Crinetics Pharmaceuticals IncNASDAQ:CRNX
- LAST PRICE45.3300
- TODAY'S CHANGE (%)-1.5600 (-3.3269%)
- Bid / Lots43.8100/ 1
- Ask / Lots47.8700/ 1
- Open / Previous Close46.1800 / 46.8900
- Day Range
- 52 Week Range
- Volume576,180
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CRNX |
|---|---|---|
| 09:32 ET | 3588 | 46.25 |
| 09:34 ET | 100 | 46.495 |
| 09:38 ET | 100 | 46.73 |
| 09:41 ET | 100 | 46.64 |
| 09:43 ET | 1911 | 46.485 |
| 09:45 ET | 548 | 46.34 |
| 09:50 ET | 1007 | 46.12 |
| 09:52 ET | 200 | 46.04 |
| 09:54 ET | 100 | 46 |
| 09:56 ET | 1000 | 46 |
| 09:59 ET | 1116 | 45.91 |
| 10:01 ET | 400 | 45.755 |
| 10:03 ET | 32047 | 45.885 |
| 10:06 ET | 1247 | 45.67 |
| 10:08 ET | 1200 | 45.64 |
| 10:10 ET | 2900 | 45.51 |
| 10:12 ET | 226 | 45.35 |
| 10:14 ET | 1550 | 45.11 |
| 10:15 ET | 1896 | 45.415 |
| 10:17 ET | 330 | 45.4001 |
| 10:19 ET | 100 | 45.5 |
| 10:21 ET | 100 | 45.4 |
| 10:24 ET | 876 | 45.66 |
| 10:26 ET | 500 | 45.6575 |
| 10:30 ET | 620 | 45.895 |
| 10:32 ET | 631 | 45.7871 |
| 10:33 ET | 559 | 45.725 |
| 10:37 ET | 242 | 45.67 |
| 10:39 ET | 319 | 45.605 |
| 10:42 ET | 100 | 45.54 |
| 10:44 ET | 200 | 45.53 |
| 10:46 ET | 6920 | 45.93 |
| 10:48 ET | 1432 | 45.99 |
| 10:50 ET | 794 | 45.93 |
| 10:51 ET | 300 | 45.93 |
| 10:53 ET | 300 | 45.85 |
| 10:55 ET | 300 | 45.92 |
| 10:57 ET | 1500 | 45.97 |
| 11:00 ET | 500 | 46.035 |
| 11:02 ET | 2557 | 46 |
| 11:04 ET | 142 | 46.005 |
| 11:06 ET | 100 | 45.97 |
| 11:08 ET | 500 | 45.83 |
| 11:09 ET | 732 | 45.75 |
| 11:13 ET | 1092 | 45.6 |
| 11:15 ET | 1900 | 45.775 |
| 11:18 ET | 687 | 45.66 |
| 11:22 ET | 100 | 45.6 |
| 11:26 ET | 957 | 45.675 |
| 11:27 ET | 200 | 45.78 |
| 11:29 ET | 915 | 45.72 |
| 11:31 ET | 622 | 45.85 |
| 11:33 ET | 1058 | 45.865 |
| 11:36 ET | 300 | 45.8 |
| 11:44 ET | 100 | 45.59 |
| 11:51 ET | 1573 | 45.42 |
| 11:54 ET | 100 | 45.445 |
| 11:56 ET | 900 | 45.4 |
| 11:58 ET | 307 | 45.39 |
| 12:00 ET | 300 | 45.38 |
| 12:02 ET | 200 | 45.41 |
| 12:07 ET | 3214 | 45.26 |
| 12:09 ET | 4518 | 45.6 |
| 12:16 ET | 250 | 45.55 |
| 12:18 ET | 551 | 45.5 |
| 12:20 ET | 200 | 45.6 |
| 12:21 ET | 240 | 45.59 |
| 12:23 ET | 200 | 45.605 |
| 12:25 ET | 600 | 45.51 |
| 12:30 ET | 100 | 45.505 |
| 12:32 ET | 380 | 45.44 |
| 12:34 ET | 3273 | 45.31 |
| 12:36 ET | 200 | 45.28 |
| 12:38 ET | 378 | 45.31 |
| 12:41 ET | 100 | 45.27 |
| 12:43 ET | 500 | 45.315 |
| 12:45 ET | 200 | 45.315 |
| 12:48 ET | 400 | 45.24 |
| 12:50 ET | 100 | 45.23 |
| 12:54 ET | 200 | 45.25 |
| 12:56 ET | 300 | 45.26 |
| 12:59 ET | 1818 | 45.39 |
| 01:01 ET | 100 | 45.41 |
| 01:06 ET | 100 | 45.34 |
| 01:08 ET | 200 | 45.395 |
| 01:10 ET | 200 | 45.41 |
| 01:12 ET | 400 | 45.43 |
| 01:14 ET | 100 | 45.46 |
| 01:15 ET | 100 | 45.43 |
| 01:17 ET | 300 | 45.51 |
| 01:19 ET | 100 | 45.47 |
| 01:24 ET | 1400 | 45.395 |
| 01:26 ET | 300 | 45.46 |
| 01:28 ET | 300 | 45.51 |
| 01:30 ET | 326 | 45.53 |
| 01:32 ET | 557 | 45.48 |
| 01:37 ET | 200 | 45.5 |
| 01:39 ET | 1261 | 45.46 |
| 01:42 ET | 1200 | 45.43 |
| 01:44 ET | 100 | 45.43 |
| 01:48 ET | 100 | 45.415 |
| 01:50 ET | 900 | 45.43 |
| 01:51 ET | 1700 | 45.53 |
| 01:53 ET | 1000 | 45.595 |
| 01:55 ET | 984 | 45.54 |
| 01:57 ET | 100 | 45.48 |
| 02:02 ET | 300 | 45.37 |
| 02:04 ET | 1102 | 45.37 |
| 02:06 ET | 545 | 45.5 |
| 02:08 ET | 1378 | 45.51 |
| 02:09 ET | 400 | 45.49 |
| 02:11 ET | 200 | 45.5 |
| 02:13 ET | 1100 | 45.54 |
| 02:15 ET | 100 | 45.525 |
| 02:18 ET | 2073 | 45.51 |
| 02:20 ET | 100 | 45.5 |
| 02:22 ET | 300 | 45.51 |
| 02:24 ET | 3326 | 45.49 |
| 02:26 ET | 100 | 45.49 |
| 02:27 ET | 500 | 45.49 |
| 02:29 ET | 200 | 45.49 |
| 02:31 ET | 500 | 45.48 |
| 02:33 ET | 2137 | 45.36 |
| 02:36 ET | 945 | 45.41 |
| 02:38 ET | 600 | 45.36 |
| 02:40 ET | 100 | 45.365 |
| 02:42 ET | 1501 | 45.37 |
| 02:44 ET | 700 | 45.42 |
| 02:47 ET | 1300 | 45.345 |
| 02:49 ET | 1180 | 45.37 |
| 02:51 ET | 400 | 45.36 |
| 02:54 ET | 100 | 45.39 |
| 02:56 ET | 400 | 45.44 |
| 02:58 ET | 500 | 45.48 |
| 03:00 ET | 500 | 45.56 |
| 03:02 ET | 482 | 45.63 |
| 03:03 ET | 300 | 45.64 |
| 03:05 ET | 1300 | 45.63 |
| 03:07 ET | 5907 | 45.615 |
| 03:09 ET | 700 | 45.56 |
| 03:12 ET | 300 | 45.58 |
| 03:14 ET | 4620 | 45.6 |
| 03:16 ET | 638 | 45.49 |
| 03:18 ET | 700 | 45.375 |
| 03:20 ET | 100 | 45.37 |
| 03:21 ET | 1000 | 45.34 |
| 03:23 ET | 500 | 45.37 |
| 03:25 ET | 100 | 45.385 |
| 03:27 ET | 2171 | 45.495 |
| 03:30 ET | 1300 | 45.54 |
| 03:32 ET | 1700 | 45.6 |
| 03:34 ET | 5310 | 45.485 |
| 03:36 ET | 24744 | 45.385 |
| 03:38 ET | 1100 | 45.32 |
| 03:39 ET | 3815 | 45.31 |
| 03:41 ET | 2101 | 45.41 |
| 03:43 ET | 3629 | 45.28 |
| 03:45 ET | 1500 | 45.33 |
| 03:48 ET | 7491 | 45.285 |
| 03:50 ET | 700 | 45.29 |
| 03:52 ET | 15798 | 45.28 |
| 03:54 ET | 10016 | 45.24 |
| 03:56 ET | 6999 | 45.43 |
| 03:57 ET | 15291 | 45.33 |
| 03:59 ET | 139192 | 45.33 |
Jun 10, 2024
Crinetics Pharmaceuticals Announces June 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 6:35PM ET on Monday Jun 10, 2024 by Dow Jones
6:35PM ET on Monday Jun 10, 2024 by Dow Jones
Jun 4, 2024
DJ Crinetics Pharmaceuticals Price Target Maintained With a $80.00/Share by JMP Securities, from 8:29AM ET on Tuesday Jun 04, 2024 by Dow Jones
8:29AM ET on Tuesday Jun 04, 2024 by Dow JonesDJ Crinetics Pharmaceuticals Is Maintained at Outperform by Oppenheimer, from 8:19AM ET on Tuesday Jun 04, 2024 by Dow Jones
8:19AM ET on Tuesday Jun 04, 2024 by Dow JonesDJ Crinetics Pharmaceuticals Price Target Maintained With a $60.00/Share by HC Wainwright & Co., from 7:37AM ET on Tuesday Jun 04, 2024 by Dow Jones
7:37AM ET on Tuesday Jun 04, 2024 by Dow Jones
Jun 3, 2024
Crinetics Announces Positive Initial Findings at ENDO 2024 for Atumelnant in Two Ongoing, Open-Label Studies for the Treatment of Congenital Adrenal Hyperplasia (CAH) and ACTH-Dependent Cushing's Syndrome (ADCS), from 12:00PM ET on Monday Jun 03, 2024 by Dow Jones
12:00PM ET on Monday Jun 03, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Crinetics Pharmaceuticals Inc | 3.6B | -12.0x | --- |
Immunovant Inc | 3.8B | -13.8x | --- |
Avidity Biosciences Inc | 3.8B | -13.4x | --- |
Dyne Therapeutics Inc | 3.3B | -8.3x | --- |
Vitaspring Biomedical Co. Ltd | 3.1B | 3,311.3x | --- |
Merus NV | 3.8B | -20.8x | --- |
Company Information
Crinetics Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its Paltusotine, an investigational, oral somatostatin receptor type 2 (SST2) agonist, is in Phase 3 clinical development for acromegaly and Phase 2 clinical development for carcinoid syndrome associated with neuroendocrine tumors. It has demonstrated pharmacologic proof-of-concept in a Phase 1 clinical study for CRN04894, an investigational, oral ACTH antagonist, that is in Phase 2 clinical studies for the treatment of congenital adrenal hyperplasia and Cushing's disease. Its drug candidates are orally delivered, small molecule new chemical entities resulting from in-house drug discovery efforts, including other programs addressing a variety of endocrine conditions such as hyperparathyroidism, polycystic kidney disease, Graves' disease, thyroid eye disease, diabetes and obesity.
Contact Information
- Headquarters
- 10222 Barnes Canyon Rd Bldg 2SAN DIEGO, CA, United States 92121-2711
- Phone
- 858-450-6464
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Wendell Wierenga
- President, Chief Executive Officer, Co-Founder, Director
- R. Scott Struthers
- Co-Founder, Chief Scientific Officer
- Stephen Betz
- Chief Financial Officer
- Marc Wilson
- Chief Operating Officer
- Jeff Knight
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.6B |
|---|---|
Revenue (TTM) | $2.0M |
Shares Outstanding | 78.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.68 |
EPS | $-3.77 |
Book Value | $7.91 |
P/E Ratio | -12.0x |
Price/Sales (TTM) | 1,810.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -12,571.38% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
